[Bilateral lymphoblastic lymphoma of the breast].
A 21-year-old female patient presenting with bilateral lymphoblastic lymphoma of the breast was given two four-week courses of cytostatic therapy using the ALL/AUL protocol. Radiation therapy was used as an adjunct. Treatment resulted in tumour regression. In the course of continued maintenance therapy neither computed tomography nor mammography nor clinical examination have so far detected any residues of a non-Hodgkin's lymphoma. It has, therefore, so far been possible to spare this young patient the mutilating consequences of mastectomy. Up to now, 27 months following start of therapy, she is again actively pursuing her professional career. There has so far been no indication of a recurrence of the lymphoma.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*
Das bilaterale lymphoblastische Lymphom der Brustdrüse.